Rna Diagnostics Inc.

🗓 Founded 2010👥 10 employees💰 Last funded 2019
Rna Diagnostics Inc. is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, RNA Disruption Assay™ (RDA™), is a novel test that helps oncologists to rapidly assess the effectiveness of cancer chemotherapy. RDA can determine whether chemotherapy is working effectively in the individual patient early in treatment thereby guiding clinical decision making.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2010
Founded
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in Rna Diagnostics Inc.?
Rna Diagnostics Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Rna Diagnostics Inc. last raise funding?
The most recent investment in Rna Diagnostics Inc. recorded on gritt.io was in 2019.
When was Rna Diagnostics Inc. founded?
Rna Diagnostics Inc. was founded in 2010.
What industry is Rna Diagnostics Inc. in?
Rna Diagnostics Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.